Vulcan Energy's shares fell 5.6% yesterday, and the temptation to pin that move on a single headline is strong. The more ...
Moderna has delivered a genuine clinical success in high-risk melanoma. Whether that success can be turned into a ...
A Rule 10b5-1 share sale by a director and GTA VI's first US TV ad are confirmed events, but neither settles Take-Two's outlook ahead of Nov 9 results.
Plug Power reports preliminary Q3 2026 revenue growth above 10% and $28M cash burn, with full results due November 9, 2026.
D-Wave fell 3.8% with tech peers on AI spending worries, while a law firm re-noticed an existing securities class action; no ...
XRP Ledger throughput is back to normal, but the fixCleanup3_4_0 amendment faces a new 14-day window and exchange reserves ...
DWS opened a Jeonju liaison office tied to its NPS relationship, while Berenberg began coverage with a Hold rating and EUR 68 target.
Western Digital rose 3.9% Wednesday as BofA raised its target to $800 and Morgan Stanley cut to $643, both keeping bullish ...
Bernstein analyst James Hooper reaffirmed a Buy rating on BASF on Tuesday, holding his price target at 61 euros. The ...
Micron Technology shares fell 6.1% on the day, caught in a worldwide selloff of AI-linked equities that has little to do with the company's own announcements. T ...
BMW has invested about EUR 400 million in Regensburg production since 2023 and begun Gen6 battery output in Shenyang as it builds Neue Klasse capacity.
BioNTech plans to amend Phase 3 ROSETTA Breast-01 to test pumitamig with Gilead's Trodelvy instead of chemotherapy; the change needs regulatory approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results